CLASSIC CONGENITAL ADRENAL HYPERPLASIA
Clinical trials for CLASSIC CONGENITAL ADRENAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new CLASSIC CONGENITAL ADRENAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for CLASSIC CONGENITAL ADRENAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to help kids with rare hormone disorder use less steroids
Disease control Recruiting nowThis study is testing an investigational drug called atumelnant in children aged 1 to 18 with a genetic hormone disorder called congenital adrenal hyperplasia (CAH). The main goals are to see if the drug is safe, if it can help control abnormal hormone levels, and if it allows ch…
Matched conditions: CLASSIC CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE2, PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill could help control rare hormone disorder, reduce steroid dependence
Disease control Recruiting nowThis study is testing whether a daily pill called atumelnant can better control hormone levels in adults with classic congenital adrenal hyperplasia (CAH), a rare genetic condition. About 150 participants will receive either atumelnant or a placebo pill for comparison. The main g…
Matched conditions: CLASSIC CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Extended trial tests new drug for rare hormone disorder
Disease control Recruiting nowThis study aims to learn about the long-term safety and effectiveness of the experimental drug atumelnant (CRN04894) for people with congenital adrenal hyperplasia (CAH), a rare genetic hormone condition. It is open to about 150 people who have already taken this drug in a previo…
Matched conditions: CLASSIC CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC